While insulin therapy prior to admission was shown to be associated with higher mortality in patients with COVID-19 (70, 71), there is a possibility that blood glucose control with insulin therapy during hospitalization leads to reductions in the risk of sever disease in these patients (72). Here, INS is linked to COVID-19.